Valeo Financial Advisors LLC Takes Position in iShares Biotechnology ETF (NASDAQ:IBB)

Valeo Financial Advisors LLC bought a new position in iShares Biotechnology ETF (NASDAQ:IBB) in the 3rd quarter, Holdings Channel reports. The firm bought 1,417 shares of the financial services provider’s stock, valued at approximately $206,000.

Several other hedge funds also recently added to or reduced their stakes in the company. Albion Financial Group UT boosted its position in shares of iShares Biotechnology ETF by 0.3% during the third quarter. Albion Financial Group UT now owns 129,980 shares of the financial services provider’s stock valued at $18,925,000 after buying an additional 356 shares during the period. Capital Insight Partners LLC lifted its stake in shares of iShares Biotechnology ETF by 5.4% during the 3rd quarter. Capital Insight Partners LLC now owns 14,431 shares of the financial services provider’s stock worth $2,101,000 after acquiring an additional 739 shares during the last quarter. Connective Portfolio Management LLC purchased a new position in iShares Biotechnology ETF during the 3rd quarter valued at $849,000. Royal Fund Management LLC bought a new position in iShares Biotechnology ETF in the 3rd quarter valued at $1,304,000. Finally, WealthCare Investment Partners LLC increased its stake in iShares Biotechnology ETF by 2.8% in the third quarter. WealthCare Investment Partners LLC now owns 10,252 shares of the financial services provider’s stock worth $1,458,000 after purchasing an additional 281 shares during the period. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Trading Up 0.1 %

NASDAQ:IBB opened at $145.82 on Wednesday. The stock has a fifty day simple moving average of $145.34 and a 200-day simple moving average of $139.50. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were given a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.